Literature DB >> 6762163

Colchicine in generalized pustular psoriasis: clinical response and antibody-dependent cytotoxicity by monocytes and neutrophils.

H Zachariae, K Kragballe, T Herlin.   

Abstract

Four patients with generalized pustular psoriasis were treated with oral colchicine in an open study. Three of the four patients went into total remission within two weeks while receiving colchicine. The monocyte- and neutrophil function was assessed by studying antibody-dependent cytotoxicity. Increased values observed before treatment decreased during treatment. The patient who responded poorest clinically also showed less changes in monocyte- and neutrophil antibody-dependent cytotoxicity.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6762163     DOI： 10.1007/bf00403737

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


  17 in total

1.  Destruction of sensitized erythrocytes by human monocytes in vitro: effects of cytochalasin B, hydrocortisone and colchicine.

Authors:  A Fleer; M L van Schaik; A E von dem Borne; C P Engelfriet
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

2.  Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.

Authors:  G S Lazarus; F J Yost; C A Thomas
Journal:  Science       Date:  1977-12-16       Impact factor: 47.728

3.  Lysosomes and gout.

Authors:  K T Rajan
Journal:  Nature       Date:  1966-05-28       Impact factor: 49.962

4.  Monocyte function in psoriasis.

Authors:  M Bar-Eli; R Gallily; H A Cohen; A Wahba
Journal:  J Invest Dermatol       Date:  1979-08       Impact factor: 8.551

5.  Therapeutic trials with oral colchicine in psoriasis.

Authors:  A Wahba; H Cohen
Journal:  Acta Derm Venereol       Date:  1980       Impact factor: 4.437

6.  Cellular requirements for the formation of EA rosettes by human monocytes.

Authors:  J H Passwell; E Schneeberger; E Merler
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

7.  On the mechanism of enhanced monocyte and neutrophil cytotoxicity in severe psoriasis.

Authors:  T Herlin; N Borregaard; K Kragballe
Journal:  J Invest Dermatol       Date:  1982-08       Impact factor: 8.551

8.  Suppression of DNCB-induced irritant dermatitis by colchicine.

Authors:  Y Miyachi; M Takigawa; S Imamura
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

9.  Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.

Authors:  R S Stern; L A Thibodeau; R A Kleinerman; J A Parrish; T B Fitzpatrick
Journal:  N Engl J Med       Date:  1979-04-12       Impact factor: 91.245

10.  Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.

Authors:  P G Hazen; B Michel
Journal:  Arch Dermatol       Date:  1979-11
View more
  3 in total

1.  Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome.

Authors:  Koji Otani; Toshio Watanabe; Sunao Shimada; Shogo Takeda; Shigehiro Itani; Akira Higashimori; Yuji Nadatani; Yasuaki Nagami; Fumio Tanaka; Noriko Kamata; Hirokazu Yamagami; Tetsuya Tanigawa; Masatsugu Shiba; Kazunari Tominaga; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

Review 2.  Colchicine in Managing Skin Conditions: A Systematic Review.

Authors:  Stefano Dastoli; Steven Paul Nisticò; Pietro Morrone; Cataldo Patruno; Antonio Leo; Rita Citraro; Luca Gallelli; Emilio Russo; Giovambattista De Sarro; Luigi Bennardo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

Review 3.  Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.

Authors:  James Krueger; Lluís Puig; Diamant Thaçi
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.